{
      "Rank": 232,
      "Acronym": [
            "ORTHOUNION"
      ],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "Autologous Cultured Mesenchymal Stem Cells +Biomaterial (Low Dose): 100x106 cells",
            "Autologous Cultured Mesenchymal Stem Cells+Biomaterial (High Dose): 200x106 cells",
            "Autologous Iliac Crest Grafting"
      ],
      "ArmGroupInterventionName": [
            "Biological: Cultured Mesenchymal Stem Cells",
            "Biological: Cultured Mesenchymal Stem Cells",
            "Procedure: Autologous iliac crest graft"
      ],
      "ArmGroupLabel": [
            "hBM-MSCs-Low Dose",
            "hBM-MSCs-High Dose",
            "Autologous iliac crest graft"
      ],
      "ArmGroupType": [
            "Experimental",
            "Experimental",
            "Active Comparator"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT03325504"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "ORTHOUNION is a multi-centre, open, comparative, randomized, clinical trial with three parallel arms that aims to compare the efficacy of three treatments to enhance bone healing in patients with long bone non-union."
      ],
      "BriefTitle": [
            "A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union"
      ],
      "CentralContactEMail": [],
      "CentralContactName": [],
      "CentralContactPhone": [],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [],
      "CollaboratorClass": [],
      "CollaboratorName": [],
      "CompletionDate": [
            "December 31, 2023"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Non Union Fracture"
      ],
      "ConditionAncestorId": [
            "D000050723",
            "D000014947"
      ],
      "ConditionAncestorTerm": [
            "Fractures, Bone",
            "Wounds and Injuries"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC26",
            "All"
      ],
      "ConditionBrowseBranchName": [
            "Wounds and Injuries",
            "All Conditions"
      ],
      "ConditionBrowseLeafAsFound": [
            "Non-Union Fractures"
      ],
      "ConditionBrowseLeafId": [
            "M25523",
            "M7872",
            "M16837"
      ],
      "ConditionBrowseLeafName": [
            "Fractures, Bone",
            "Fractures, Ununited",
            "Wounds and Injuries"
      ],
      "ConditionBrowseLeafRelevance": [
            "low",
            "high",
            "low"
      ],
      "ConditionMeshId": [
            "D000005599"
      ],
      "ConditionMeshTerm": [
            "Fractures, Ununited"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Randomized"
      ],
      "DesignInterventionModel": [
            "Parallel Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [
            "Bone injuries represent an important world medical problem producing significant healthcare and societal expenditure. While most bone injuries are not severe and are capable of healing through bone regeneration by natural callus formation with standard treatments, severe bone injuries may not heal, becoming an important unmet clinical need.\n\nNon-unions, or pseudarthrosis, may occur in 5% to 20% of long-bone fractures that fail to heal properly after more than 6 months, with morbidity, prolonged hospitalization, and increased expenses. The most commonly accepted standard augmentation to procure fracture and non-union healing consists of autologous bone grafting, obtained from the same patient in a different surgical site and transplanted to the reconstruction site. However, autologous bone grafting has some drawbacks (such as persistent pain, scar, late recovery, limited amount of bone, etc) and a limited regeneration efficacy (success rate of about 74%) and high societal cost. Culture-expanded autologous MSCs combined with biphasic calcium phosphate (BCP) biomaterial granules have been claimed as a solid regenerative medicine alternative to autologous bone grafting in non-unions, although current data are limited. In this context, the ORTHOUNION initiative focuses on the opportunity to test the hypothesis of superiority of MSC, the investigational ATMP, versus the currently accepted standard therapy, iliac crest bone autograft to biologically augment surgical treatment of long-bone non-unions."
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nAge 18 years and older, both sexes\nTraumatic isolated closed or open Gustilo I and II, IIIA and IIIB humerus, tibial or femur diaphyseal or metaphysodiaphyseal fracture with a status of atrophic, oligotrophic or normotrophic non-union.\nAble to understand, accept and sign informed consent\nMedical health coverage\nAble to understand and accept the study constraints\n\nExclusion Criteria:\n\nHypertrophic non-unions\nSegmental bone loss requiring specific therapy (bone transport, vascularized graft, large structural allograft, megaprosthesis, etc)\nUnrecovered vascular or neural injury\nOther fractures causing interference with weight bearing\nVisceral injuries or diseases interfering with callus formation (severe cranioencephalic trauma, etc.)\nActive infection of any location and aetiology\nSurgical contraindication of any cause\nPregnancy, breast feeding women and women who are of childbearing age and not practicing adequate birth control.\nMalignant tumour (past history or concurrent disease)(except carcinoma in situ or basalioma in remission)\nHistory of bone harvesting on iliac crest contraindicating new iliac crest bone graft harvesting or bone marrow collection\nInsulin dependent diabetes\nAny evidence (confirmed by PCR) of active infection with HIV, Hepatitis B or Hepatitis C infection\nAny evidence of Syphilis\nKnown allergies to products involved in the production process of MSC\nCorticoid or immunosuppressive therapy more than one week in the three months prior to study inclusion\nAutoimmune inflammatory disease\nCurrent treatment by biphosphonates not stopped three months prior to study inclusion\nImpossibility to meet at the appointments for the follow up\nParticipation in another therapeutic trial in the previous 3 months\nSecond non-union in case of bilateral or multiple non-unions (only one non-union per patient will be included in the trial)"
      ],
      "EnrollmentCount": [
            "46"
      ],
      "EnrollmentType": [
            "Actual"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "hBM-MSCs-High Dose",
            "hBM-MSCs-Low Dose",
            "Autologous iliac crest graft"
      ],
      "InterventionBrowseBranchAbbrev": [],
      "InterventionBrowseBranchName": [],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [],
      "InterventionBrowseLeafName": [],
      "InterventionBrowseLeafRelevance": [],
      "InterventionDescription": [
            "Cultured Mesenchymal Stem Cells obtained from expanded bone marrow",
            "Autologous iliac crest grafting"
      ],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "Cultured Mesenchymal Stem Cells",
            "Autologous iliac crest graft"
      ],
      "InterventionOtherName": [],
      "InterventionType": [
            "Biological",
            "Procedure"
      ],
      "IsFDARegulatedDevice": [
            "No"
      ],
      "IsFDARegulatedDrug": [
            "No"
      ],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "Non-union",
            "Advanced therapies",
            "Mesenchymal stem cells",
            "Long bone"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [],
      "LastUpdatePostDate": [
            "June 1, 2022"
      ],
      "LastUpdatePostDateType": [
            "Actual"
      ],
      "LastUpdateSubmitDate": [
            "May 26, 2022"
      ],
      "LeadSponsorClass": [
            "OTHER"
      ],
      "LeadSponsorName": [
            "Universidad Autonoma de Madrid"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Clermont-Ferrand",
            "Cr\u00e9teil",
            "Nantes",
            "Toulouse",
            "Tours",
            "Frankfurt",
            "Freiburg",
            "Munich",
            "Ulm",
            "Bologna",
            "Brescia",
            "Milano",
            "Majadahonda",
            "Madrid",
            "Madrid",
            "Madrid",
            "Madrid",
            "Madrid",
            "Madrid"
      ],
      "LocationContactEMail": [],
      "LocationContactName": [],
      "LocationContactPhone": [],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [],
      "LocationCountry": [
            "France",
            "France",
            "France",
            "France",
            "France",
            "Germany",
            "Germany",
            "Germany",
            "Germany",
            "Italy",
            "Italy",
            "Italy",
            "Spain",
            "Spain",
            "Spain",
            "Spain",
            "Spain",
            "Spain",
            "Spain"
      ],
      "LocationFacility": [
            "CHU Clermont-Ferrand",
            "Department of Orthopaedic Surgery, Hospital Henri Mondor",
            "Department of Orthopaedic Surgery, CHU Nantes",
            "Department of Orthopaedic Surgery Toulouse University Hospital",
            "Department of Orthopaedic Surgery, CHU Tours",
            "Universit\u00e4tsklinikum Frankfurt, Department of Trauma, Hand and Reconstructive Surgery",
            "Universit\u00e4tsklinikum Freiburg, Klinik f\u00fcr Orthop\u00e4die und Unfallchirurgie",
            "Universit\u00e4tsklinikum M\u00fcnchen",
            "Department of Orthopaedic Trauma, University of Ulm",
            "Istituto Ortopedico Rizzoli, SSD Fisiopatologia Ortopedica e Medicina Rigenerativa",
            "Arienda Spedali Civili di Brescia II Ortopedia e Traumatologia",
            "Istituto Ortopedico Galeazzi, Chirugia dell\u00b4Anca l",
            "Hospital U. Puerta de Hierro-Majadahonda, Servicio de Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda",
            "Hospital Cl\u00ednica San Carlos, Servicio de Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda",
            "Hospital U. 12 de Octubre, Servicio de Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda",
            "Hospital U. Gregorio Mara\u00f1on, Servicio de Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda",
            "Hospital U. La Princesa, Servicio de Cirug\u00edaOrtop\u00e9dica y Traumatolog\u00eda",
            "Hospital Universitario Ram\u00f3n y Cajal",
            "Servicio de Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda \"A\", Hospital La Paz"
      ],
      "LocationState": [
            "Madrid"
      ],
      "LocationStatus": [],
      "LocationZip": [
            "37044",
            "8907581",
            "40136"
      ],
      "MaximumAge": [
            "99 Years"
      ],
      "MinimumAge": [
            "18 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "A Multi-centre, Open-label, Randomized, Comparative Clinical Trial of Two Doses of Bone Marrow Autologous MSC+ Biomaterial vs Iliac Crest Autologous Graft, for Bone Healing in Non-union After Long Bone Fractures"
      ],
      "OrgClass": [
            "OTHER"
      ],
      "OrgFullName": [
            "Universidad Autonoma de Madrid"
      ],
      "OrgStudyId": [
            "ORTHOUNION"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "UAM"
      ],
      "OverallOfficialName": [
            "Enrique Gomez-Barrena, Prof"
      ],
      "OverallOfficialRole": [
            "Principal Investigator"
      ],
      "OverallStatus": [
            "Active, not recruiting"
      ],
      "OversightHasDMC": [
            "Yes"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 3"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "December 30, 2022"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [
            "The percentage of bone consolidation in the comparator treatment arm ( iliac crest autograft) and experimental treatment arm (mesenchymal cells)."
      ],
      "PrimaryOutcomeMeasure": [
            "Bone consolidation"
      ],
      "PrimaryOutcomeTimeFrame": [
            "12 months after treatment"
      ],
      "ReferenceCitation": [
            "G\u00f3mez-Barrena E, Padilla-Eguiluz NG, Avenda\u00f1o-Sol\u00e1 C, Payares-Herrera C, Velasco-Iglesias A, Torres F, Rosset P, Gebhard F, Baldini N, Rubio-Suarez JC, Garc\u00eda-Rey E, Cordero-Ampuero J, Vaquero-Martin J, Chana F, Marco F, Garc\u00eda-Coiradas J, Caba-Dessoux P, de la Cuadra P, Hernigou P, Flouzat-Lachaniette CH, Gouin F, Mainard D, Laffosse JM, Kalbitz M, Marzi I, S\u00fcdkamp N, St\u00f6ckle U, Ciapetti G, Donati DM, Zagra L, Pazzaglia U, Zarattini G, Capanna R, Catani F. A Multicentric, Open-Label, Randomized, Comparative Clinical Trial of Two Different Doses of Expanded hBM-MSCs Plus Biomaterial versus Iliac Crest Autograft, for Bone Healing in Nonunions after Long Bone Fractures: Study Protocol. Stem Cells Int. 2018 Feb 22;2018:6025918. doi: 10.1155/2018/6025918. eCollection 2018."
      ],
      "ReferencePMID": [
            "29535772"
      ],
      "ReferenceType": [
            "background"
      ],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [
            "Universidad Autonoma de Madrid"
      ],
      "ResponsiblePartyInvestigatorFullName": [
            "Prof Enrique Gomez-Barrena"
      ],
      "ResponsiblePartyInvestigatorTitle": [
            "Full Professor and Chair of orthopaedic surgery"
      ],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Principal Investigator"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [
            "2015-000431-32",
            "EUCTR2015-000431-32-ES"
      ],
      "SecondaryIdDomain": [
            "International Clinical Trials Registry Plataform"
      ],
      "SecondaryIdLink": [],
      "SecondaryIdType": [
            "EudraCT Number",
            "Registry Identifier"
      ],
      "SecondaryOutcomeDescription": [
            "To compare bone consolidation between the experimental arms and the comparator",
            "To compare bone consolidation, using the REBORNE scale, between the experimental arms and the comparator.\n\nThe REBORNE scale is an ad-hoc and validated scale, developed by Gomez-Barrena et al. (article currently under preparation) as a modification of the RUST score (Whelan, 2010; Journal of Trauma). In the REBORNE scale, the presence/absence of radiological consolidation is evaluated on a total of 4 cortices. Score range from 0 (no bone callus visible) to 4 (callus present with same density as cortical). The total score will be recorded.",
            "To compare level of pain (by Numeric Rating Scale [NRS]) between the experimental arms and the comparator.\n\nThe NRS is a scale that rates the patient\u00b4s pain from 0-10 (0= no pain, 10= worst pain), at the time of the visit.",
            "To compare the rate of complications between the experimental arms and the comparator",
            "To compare the health status (by using the Short Form-36 Health Questionnaire) between treatment arms.\n\nThe SF-36 questionnaire is a validated, widely used patient-reported health survey which measures their physical and mental health status. It consists of 36 questions organized in 8 dimensions. The total score will be recorded."
      ],
      "SecondaryOutcomeMeasure": [
            "Bone consolidation",
            "Radiological Bone consolidation",
            "Level of Pain",
            "Complications",
            "Health status"
      ],
      "SecondaryOutcomeTimeFrame": [
            "6 and 24 months",
            "6, 12 and 24 months",
            "6, 12 and 24 months",
            "6, 12 and 24 months",
            "6, 12 and 24 months"
      ],
      "SeeAlsoLinkLabel": [
            "Webpage of the Orthounion Study"
      ],
      "SeeAlsoLinkURL": [
            "http://orthounion.eu"
      ],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "September 5, 2017"
      ],
      "StartDateType": [
            "Actual"
      ],
      "StatusVerifiedDate": [
            "May 2022"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "October 30, 2017"
      ],
      "StudyFirstPostDateType": [
            "Actual"
      ],
      "StudyFirstSubmitDate": [
            "October 25, 2017"
      ],
      "StudyFirstSubmitQCDate": [
            "October 25, 2017"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": []
}